TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
GERN

Geron Corporation

Healthcare · Biotechnology

1.20$ -5.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

Geron Corporation (GERN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 57 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GERN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.2 0.0 0.3 0.9 28 48 40 49 47 48 52 57 205
29 0.2 0.3 0.0 0.5 0.8 1.2 1.2 22 1.3 1.7 9.2 34
0.2 0.0 0.3 0.9 28 47 38 48 25 47 50 48 170
29 33 29 31 20 23 15 22 21 16 15 22 74
18 21 27 39 36 43 40 39 39 42 35 39 155
48 54 56 70 56 67 55 60 39 57 50 61 208
-48 -54 -56 -69 -28 -20 -17 -12 -14 -11 -0.2 -12 -37
2.1 2.3 3.4 3.3 3.0 8.7 8.2 8.5 8.6 7.3 7.1 7.1 30
-45 -52 -55 -67 -26 -25 -20 -16 -18 -31 -3.6 -17 -70
-0.3 0.2 0.2 -26
-45 -52 -55 -67 -26 -25 -20 -16 -18 -31 -3.6 -17 -70
-42 -49 -52 -64 -23 -16 -11 -7.6 -9.7 -24 3.8 -12 -42

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?